Functional activity of the complement regulator encoded by Kaposi's sarcoma-associated herpesvirus
- PMID: 12645526
- DOI: 10.1074/jbc.m211579200
Functional activity of the complement regulator encoded by Kaposi's sarcoma-associated herpesvirus
Abstract
Kaposi's sarcoma-associated herpesvirus (KSHV) is closely associated with Kaposi's sarcoma and certain B-cell lymphomas. The fourth open reading frame of the KSHV genome encodes a protein (KSHV complement control protein (KCP, previously termed ORF4)) predicted to have complement-regulating activity. Here, we show that soluble KCP strongly enhanced the decay of classical C3-convertase but not the alternative pathway C3-convertase, when compared with the host complement regulators: factor H, C4b-binding protein, and decay-accelerating factor. The equilibrium affinity constant (KD) of KCP for C3b and C4b was determined by surface plasmon resonance analysis to range between 0.47-10 microM and 0.025-6.1 microM, respectively, depending on NaCl concentration and cation presence. Soluble and cell-associated KCP acted as a cofactor for factor I (FI)-mediated cleavage of both C4b and C3b and induced the cleavage products C4d and iC3b, respectively. In the presence of KCP, FI further cleaved iC3b to C3d, which has never been described before as complement receptor 1 only mediates the production of C3dg by FI. KCP would enhance virus pathogenesis through evading complement attack, opsonization, and anaphylaxis but may also aid in targeting KSHV to one of its host reservoirs since C3d is a ligand for complement receptor 2 on B-cells.
Similar articles
-
The Kaposi's sarcoma-associated herpesvirus complement control protein mimics human molecular mechanisms for inhibition of the complement system.J Biol Chem. 2004 Oct 22;279(43):45093-101. doi: 10.1074/jbc.M407558200. Epub 2004 Aug 10. J Biol Chem. 2004. PMID: 15304516
-
Separation of decay-accelerating and cofactor functional activities of Kaposi's sarcoma-associated herpesvirus complement control protein using monoclonal antibodies.Immunology. 2008 Feb;123(2):228-38. doi: 10.1111/j.1365-2567.2007.02692.x. Epub 2007 Aug 30. Immunology. 2008. PMID: 17764451 Free PMC article.
-
Dissecting the regions of virion-associated Kaposi's sarcoma-associated herpesvirus complement control protein required for complement regulation and cell binding.J Virol. 2006 Apr;80(8):4068-78. doi: 10.1128/JVI.80.8.4068-4078.2006. J Virol. 2006. PMID: 16571823 Free PMC article.
-
Kaposi's sarcoma-associated herpes virus complement control protein: KCP--complement inhibition and more.Mol Immunol. 2007 Jan;44(1-3):11-22. doi: 10.1016/j.molimm.2006.06.018. Epub 2006 Aug 14. Mol Immunol. 2007. PMID: 16905191 Review.
-
Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma.Microbes Infect. 2000 May;2(6):671-80. doi: 10.1016/s1286-4579(00)00358-0. Microbes Infect. 2000. PMID: 10884618 Review.
Cited by
-
Molecular biology of KSHV in relation to AIDS-associated oncogenesis.Cancer Treat Res. 2007;133:69-127. doi: 10.1007/978-0-387-46816-7_3. Cancer Treat Res. 2007. PMID: 17672038 Free PMC article. Review.
-
Kaposi sarcoma-associated herpesvirus: immunobiology, oncogenesis, and therapy.J Clin Invest. 2016 Sep 1;126(9):3165-75. doi: 10.1172/JCI84418. Epub 2016 Sep 1. J Clin Invest. 2016. PMID: 27584730 Free PMC article. Review.
-
Kaposi's sarcoma-associated herpesvirus and innate immunity.Future Virol. 2010 Mar 1;5(2):185-196. doi: 10.2217/fvl.10.5. Future Virol. 2010. PMID: 20414330 Free PMC article.
-
Complement Proteins as Soluble Pattern Recognition Receptors for Pathogenic Viruses.Viruses. 2021 May 2;13(5):824. doi: 10.3390/v13050824. Viruses. 2021. PMID: 34063241 Free PMC article. Review.
-
The Interactions of the Complement System with Human Cytomegalovirus.Viruses. 2024 Jul 20;16(7):1171. doi: 10.3390/v16071171. Viruses. 2024. PMID: 39066333 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous